The Bottom Line Foundayo (orforglipron) is a real, FDA-approved oral GLP-1 medication that eliminates the injection and fasting barriers that have kept many eligible patients from starting GLP-1 therapy
Some improvements in NITs were related to the treatment arm but not per se to histological response, whereas others, e.g
Relatively affordable : Monthly rates are generally less expensive than those of competitors who primarily prescribe brand-name GLP-1 medications
With the same GLP-1 science as the injectable form, this daily tablet suits those who prefer oral administration
"This medication has led to significant amounts of weight loss, but when it stops, patients have reported gaining up to two-thirds of that weight back," Sutton said, citing published research
Fewer reconstitutions means more consistent potency across your protocol